Ractigen Therapeutics Publishes Foundational Study on its Extrahepatic LiCO™ Delivery Platform in Molecular Therapy

A peer-reviewed study reports potent, multi-month extrahepatic delivery via systemic administration to skeletal muscle, heart and adipose tissue, as well as localized delivery to ocular, joint and bladder compartments. The findings point to potential access to high-value therapeutic tissues, but the provided article text gives no study-level figures or clinical outcomes.